Yeah I was a bit surprised at that too. Might follow it up later. Best case is the inference is that those pharma are returning to PYC eg Genentech but worst case is he has misunderstood. I think they point he is trying to make is that each partnership progressed the science to a more valuable proposition that is still progressing towards a financial outcome.
The lack of a wider following here on HC is still a great indication that so few know about this story. As soon as 1 broker (Euroz) started covering it demand picked up - imagine when the story is more broadly told.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)